|
hindbrain neural keel
|
UBERON_2007029 |
|
|
regulation of glucocorticoid receptor signaling pathway
|
GO_2000322 |
[Any process that modulates the frequency, rate or extent of glucocorticoid receptor signaling pathway.] |
|
regulation of intracellular steroid hormone receptor signaling pathway
|
GO_0033143 |
[Any process that modulates the frequency, rate or extent of the activity of any intracellular steroid hormone receptor signaling pathway.] |
|
negative regulation of glucocorticoid receptor signaling pathway
|
GO_2000323 |
[Any process that stops, prevents or reduces the frequency, rate or extent of glucocorticoid receptor signaling pathway.] |
|
negative regulation of intracellular steroid hormone receptor signaling pathway
|
GO_0033144 |
[Any process that stops, prevents, or reduces the frequency, rate or extent of the activity of any intracellular steroid hormone receptor signaling pathway.] |
|
salt transmembrane transporter activity
|
GO_1901702 |
[Enables the transfer of salt from one side of a membrane to the other.] |
|
mesenchymal cell differentiation involved in bone development
|
GO_1901706 |
[The process in which relatively unspecialized cells acquire specialized structural and/or functional features that characterize the mesenchymal cells of bone as it progresses from its formation to the mature state.] |
|
positive regulation of glucocorticoid receptor signaling pathway
|
GO_2000324 |
[Any process that activates or increases the frequency, rate or extent of glucocorticoid receptor signaling pathway.] |
|
positive regulation of intracellular steroid hormone receptor signaling pathway
|
GO_0033145 |
[Any process that activates or increases the frequency, rate or extent of the activity of any intracellular steroid hormone receptor signaling pathway.] |
|
C19-steroid
|
CHEBI_131621 |
[A steroid compound with a structure based on a 19-carbon (androstane) skeleton.] |
|
regulation of gamma-aminobutyric acid catabolic process
|
GO_1901715 |
[Any process that modulates the frequency, rate or extent of gamma-aminobutyric acid catabolic process.] |
|
negative regulation of gamma-aminobutyric acid catabolic process
|
GO_1901716 |
[Any process that stops, prevents or reduces the frequency, rate or extent of gamma-aminobutyric acid catabolic process.] |
|
positive regulation of gamma-aminobutyric acid catabolic process
|
GO_1901717 |
[Any process that activates or increases the frequency, rate or extent of gamma-aminobutyric acid catabolic process.] |
|
regulation of synaptic vesicle exocytosis
|
GO_2000300 |
[Any process that modulates the frequency, rate or extent of synaptic vesicle exocytosis.] |
|
regulation of regulated secretory pathway
|
GO_1903305 |
[Any process that modulates the frequency, rate or extent of regulated secretory pathway.] |
|
negative regulation of synaptic vesicle exocytosis
|
GO_2000301 |
[Any process that stops, prevents or reduces the frequency, rate or extent of synaptic vesicle exocytosis.] |
|
negative regulation of regulated secretory pathway
|
GO_1903306 |
[Any process that stops, prevents or reduces the frequency, rate or extent of regulated secretory pathway.] |
|
positive regulation of ceramide biosynthetic process
|
GO_2000304 |
[Any process that activates or increases the frequency, rate or extent of ceramide biosynthetic process.] |
|
regulation of ceramide biosynthetic process
|
GO_2000303 |
[Any process that modulates the frequency, rate or extent of a ceramide biosynthetic process.] |
|
positive regulation of sphingolipid biosynthetic process
|
GO_0090154 |
[Any process that increases the rate, frequency or extent of sphingolipid biosynthesis. Sphingolipid biosynthesis is the chemical reactions and pathways resulting in the formation of sphingolipids, any of a class of lipids containing the long-chain amine diol sphingosine or a closely related base (a sphingoid).] |